FDA Approved: MOEXIPRIL HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Moexipril hydrochloride (Teva), signaling changes to the drug's label under the ANDA process.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Moexipril hydrochloride (Moexipril hydrochloride)

Snippet

SUPPL AP for MOEXIPRIL HYDROCHLORIDE (MOEXIPRIL HYDROCHLORIDE)